Monthly Archives: May 2013

Featured Stories

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Yale’s Infuse® Bone Graft Study Expected in June

Yale_Infuse_Bone_Graft_study

A Yale University report concerning the bone graft product Infuse® is expected out next month. Device maker, Medtronic, commissioned Yale University researchers to conduct independent studies of its Infuse® bone graft products, allegedly in response to a June 2011 report … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Blood Cancer, Rheumatoid Arthritis Drug, MabThera, Linked to Severe Skin Reactions

Mabthera-Skin-Reactions

Roche Products Limited just issued a letter to healthcare providers in cooperation with the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) concerning the use of MabThera (rituximab) and severe skin reactions. According to Roche, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Januvia, Byetta, Other Diabetes Drugs Focus of Controversy

Januvia_Diabetes

Some popular and money making diabetes drugs are at the center of a conflict over disturbing research findings. Although Dr. Peter C. Butler declined to test its then-new diabetes medication, Januvia, he ultimately relented and, in 2008, observed that the … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Supreme Court of New Jersey Centralizes Mirena® IUD Litigation

Mirena_NJ_Supreme_Court

The Supreme Court of New Jersey just reconsidered a prior decision and is centralizing all Mirena® intrauterine device (IUD) litigation in Bergen County, New Jersey. This will enable the process to move more efficiently given that many of the plaintiffs … Continue reading

Posted in Defective Medical Devices, Mirena IUD |

Study: Zyprexa, Other Antipsychotics, Associated with Increased Risks for Torsade de Pointes

Zyprexa_Torsade

A recent study has found that some antipsychotic drugs were associated with increased risks for developing torsade de pointes (TdP), a type of abnormal heart rhythm, and other adverse events. Zyprexa was among the drugs studied. For their research, the … Continue reading

Posted in Pharmaceuticals |

EPA Proposes Stricter Rules over Formaldehyde Exposure

Formaldyhyde-Exposure

The U.S. Environmental Protection Agency (EPA) just proposed two rules to protect Americans from exposure to the harmful chemical, formaldehyde. The rules are consistent with a 2010 Federal law unanimously passed by Congress. The rules ensure that domestically produced or … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Wal-Mart Pleads Guilty to Federal Environmental Crimes, Civil Violations, to Pay More Than $81 Million

Walmart_Pleads_Guilty

Wal-Mart has admitted to violating criminal and civil laws meant to protect water quality and ensure proper handling of hazardous wastes and pesticides, the Environmental Protection Agency (EPA) announced. The retailer pleaded guilty to six counts of violating the Clean … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Experts Question Drugmakers’ Push to Treat Low Testosterone

Low-Testoterone

Drugmakers are lavishing millions of dollars on ads promoting the wonders of testosterone treatment, but they overhype the benefits and underplay the risks, according to Consumer Reports magazine. The print and television ads, primarily for two products, AndroGel and Axiron, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Study: Pesticide Exposure Increases Risks for Parkinson’s Disease

Pesticide_Exposure

For not the first time, a study suggests a link between Parkinson’s disease and pesticide exposure. Parkinson’s disease is a progressive, degenerative central nervous system disorder that typically affects motor skills and speech, among other functions and, while not fatal, … Continue reading

Posted in Health Concerns, Paraquat, PCBs, Perchlorate, Toxic Substances |

Yale’s Medtronic Reporting Expected Next Month

Yale_Medtronic_Reporting

As the fallout from a conflict-of-interest scandal continues, drug maker Medtronic, announced in its fiscal fourth-quarter earnings report that the results from a long-awaited Yale review are expected to be published next month. Medtronic has been the focus of a … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.